Phase I | Search

Trials

64 participants

Completed

NCT03318341

TheraBracelet Phase I

26 participants · First posted Oct 23, 2017

Recruiting

RPCEC00000076

rTMS-stroke-phase I

30 participants

Drugs

View all 716 →

Small Molecule

Investigational

Mirdametinib(Ezmekly, Gomekli)

Manufacturer: Merck Serono

Conditions: Neurofibromatosis Type 1, Plexiform Neurofibroma

C₁₆H₁₄F₃IN₂O₄

Biotech

Investigational

Tiragolumab

Conditions: Non-small cell lung cancer

monoclonal antibody

GB-0895

Manufacturer: Generate:Biomedicines

Conditions: severe asthma, COPD

Organizations

View all 120 →

Wuhan Healthgen Biotechnology Corp.

Regulus Therapeutics

United States

Cardiol Therapeutics Inc

Canada

News

View all 22338 →

last year

Vici Health Sciences Launches Clinical Supplies Manufacturing Services for All Trial Phases

last year

Kashiv Biosciences' Abatacept Biosimilar KSHB002 Meets Primary Endpoints in Phase I Trial

last year

Trials

nithiol Phase I

TheraBracelet Phase I

rTMS-stroke-phase I

Drugs

Mirdametinib(Ezmekly, Gomekli)

Tiragolumab

GB-0895

Organizations

Wuhan Healthgen Biotechnology Corp.

Regulus Therapeutics

Cardiol Therapeutics Inc

News

Vici Health Sciences Launches Clinical Supplies Manufacturing Services for All Trial Phases

Kashiv Biosciences' Abatacept Biosimilar KSHB002 Meets Primary Endpoints in Phase I Trial

Roche's NXT007 Achieves Zero Bleeds in Phase I/II Hemophilia A Trial, Advances to Phase III